X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Fulford India with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FULFORD INDIA vs LUPIN LTD - Comparison Results

FULFORD INDIA    Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FULFORD INDIA LUPIN LTD FULFORD INDIA/
LUPIN LTD
 
P/E (TTM) x 398.8 16.8 2,370.9% View Chart
P/BV x 6.2 3.9 158.6% View Chart
Dividend Yield % 0.1 0.8 10.8%  

Financials

 FULFORD INDIA   LUPIN LTD
EQUITY SHARE DATA
    FULFORD INDIA
Mar-14
LUPIN LTD
Mar-16
FULFORD INDIA/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs9422,127 44.3%   
Low Rs4501,294 34.8%   
Sales per share (Unadj.) Rs691.4304.1 227.4%  
Earnings per share (Unadj.) Rs11.550.4 22.7%  
Cash flow per share (Unadj.) Rs15.460.7 25.3%  
Dividends per share (Unadj.) Rs2.007.50 26.7%  
Dividend yield (eoy) %0.30.4 65.5%  
Book value per share (Unadj.) Rs380.0243.8 155.9%  
Shares outstanding (eoy) m3.90450.58 0.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.05.6 17.9%   
Avg P/E ratio x60.733.9 178.9%  
P/CF ratio (eoy) x45.328.2 160.8%  
Price / Book Value ratio x1.87.0 26.1%  
Dividend payout %17.414.9 117.2%   
Avg Mkt Cap Rs m2,714770,740 0.4%   
No. of employees `0000.416.4 2.7%   
Total wages/salary Rs m50521,077 2.4%   
Avg. sales/employee Rs Th6,073.08,379.6 72.5%   
Avg. wages/employee Rs Th1,137.41,289.0 88.2%   
Avg. net profit/employee Rs Th100.71,388.7 7.2%   
INCOME DATA
Net Sales Rs m2,696137,016 2.0%  
Other income Rs m1251,877 6.7%   
Total revenues Rs m2,822138,893 2.0%   
Gross profit Rs m-4637,535 -0.1%  
Depreciation Rs m154,635 0.3%   
Interest Rs m10446 2.1%   
Profit before tax Rs m5434,330 0.2%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1011,536 0.1%   
Profit after tax Rs m4522,707 0.2%  
Gross profit margin %-1.727.4 -6.3%  
Effective tax rate %17.733.6 52.6%   
Net profit margin %1.716.6 10.0%  
BALANCE SHEET DATA
Current assets Rs m1,73897,790 1.8%   
Current liabilities Rs m54553,872 1.0%   
Net working cap to sales %44.332.1 138.1%  
Current ratio x3.21.8 175.8%  
Inventory Days Days4885 57.2%  
Debtors Days Days4121 3.6%  
Net fixed assets Rs m1286,379 0.0%   
Share capital Rs m39901 4.3%   
"Free" reserves Rs m1,443105,735 1.4%   
Net worth Rs m1,482109,844 1.3%   
Long term debt Rs m053,739 0.0%   
Total assets Rs m2,077224,378 0.9%  
Interest coverage x6.777.9 8.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.30.6 212.6%   
Return on assets %2.610.3 25.3%  
Return on equity %3.020.7 14.6%  
Return on capital %4.321.2 20.3%  
Exports to sales %049.1 0.0%   
Imports to sales %24.57.4 328.5%   
Exports (fob) Rs mNA67,244 0.0%   
Imports (cif) Rs m65910,199 6.5%   
Fx inflow Rs m1771,405 0.0%   
Fx outflow Rs m67317,807 3.8%   
Net fx Rs m-65653,598 -1.2%   
CASH FLOW
From Operations Rs m90-3,690 -2.4%  
From Investments Rs m105-69,434 -0.2%  
From Financial Activity Rs m-1458,126 -0.0%  
Net Cashflow Rs m181-14,998 -1.2%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 3.8 11.3 33.6%  
FIIs % 0.1 31.9 0.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.2 10.1 209.9%  
Shareholders   4,783 98,259 4.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FULFORD INDIA With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare FULFORD INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Coal India Stock Rallies 4.2%(Closing)

Indian share markets finished some selling pressure in the final hour of trade to finish flat amid weak European markets.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FULFORD INDIA SHARE PRICE


Jul 30, 2015 (Close)

TRACK FULFORD INDIA

  • Track your investment in FULFORD INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FULFORD INDIA 8-QTR ANALYSIS

COMPARE FULFORD INDIA WITH

MARKET STATS